[1]CurrentPatentAssignee:SIOGENETHERAPIESINC-WO2017/69980,2017,A1Locationinpatent:Paragraph00397
[1]CurrentPatentAssignee:SIOGENETHERAPIESINC-WO2017/69980,2017,A1
1260664-41-2
209286-73-7
630421-73-7
7742-73-6
24188-80-5
634-47-9
122110-53-6 | (Pivaloyloxy)methyl butyrate | AA007P4N | MFCD00209896
221087-47-4 | N-(6-BROMOPYRIDIN-2-YL)PIVALAMIDE | AA007PIW | MFCD08235018
22064-40-0 | (2-amino-2-oxoethoxy)acetic acid | AA007PVJ | MFCD00176328
204078-93-3 | 2-(4-Methyl-1,4-diazepan-1-yl)benzonitrile | AA007QCJ | MFCD09065002
1175788-58-5 | 4-Iodo-1-vinyl-1H-pyrazole | AA007QUC | MFCD12198431
19499-61-7 | N-Methyl-n-(3-nitrobenzyl)amine | AA007RBQ | MFCD04115408
184637-50-1 | N-Methyl-1-(1-methylpiperidin-2-yl)methanamine | AA007S06 | MFCD05864522
18588-61-9 | 2,4-Diaminopyrimidine-5-carboxylic acid | AA007SPQ | MFCD09878517
112372-07-3 | Furo[3,2-c]pyridine-2-carbaldehyde | AA007TFH | MFCD15143903
17106-15-9 | 5-Acetyl-2,4-dimethyl-1h-pyrrole-3-carboxylic acid | AA007U63 | MFCD00982313